Origin has developed a patented, portable device with a handheld, computer-guided system that generates nitric oxide (NO) from ambient room air within a defined plasma stream. This plasma-generated NO is safely delivered directly to the target treatment area. The plasma-generated NO interacts with human tissue to mediate disease effects.

Medtech regulatory model, Pharma commercial model.

Our Clinical Pipeline


Wound Care & Dermal Applications

The skin is the body’s barrier to the outside world, and its largest organ. Many diseases result in skin problems, including chronic and acute wounds, and dermatological issues such as acne, eczema and psoriasis. All of these conditions can have a major impact on quality of life.

The market for dermal care is estimated to be in excess of $45bn with a CAGR of >6%. Our initial clinical focus is the market for diabetic foot ulcers (DFU’s).


adults-bed-black-and-white-1487952.jpg

Anti-infective Applications

The following is placeholder text known as “lorem ipsum,” which is scrambled Latin used by designers to mimic real copy. Nulla lectus ante, consequat et ex eget, feugiat tincidunt metus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae. Fusce at massa nec sapien auctor gravida in in tellus. Sed a ligula quis sapien lacinia egestas.


edited.jpg

Musculoskeletal

The following is placeholder text known as “lorem ipsum,” which is scrambled Latin used by designers to mimic real copy. Nulla lectus ante, consequat et ex eget, feugiat tincidunt metus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae. Fusce at massa nec sapien auctor gravida in in tellus. Sed a ligula quis sapien lacinia egestas.